Recent scientific breakthroughs, celebrity patient advocates, and conflicting religious beliefs have come together to bring the state of stem cell researchâ€"specifically embryonic stem cell researchâ€"into the political crosshairs. President Bush's watershed policy statement allows federal funding for embryonic stem cell research but only on a limited number of stem cell lines. Millions of Americans could be affected by the continuing political debate among policymakers and the public. Stem Cells and the Future of Regenerative Medicine provides a deeper exploration of the biological, ethical, and funding questions prompted by the therapeutic potential of undifferentiated human cells. In terms accessible to lay readers, the book summarizes what we know about adult and embryonic stem cells and discusses how to go about the transition from mouse studies to research that has therapeutic implications for people. Perhaps most important, Stem Cells and the Future of Regenerative Medicine also provides an overview of the moral and ethical problems that arise from the use of embryonic stem cells. This timely book compares the impact of public and private research funding and discusses approaches to appropriate research oversight. Based on the insights of leading scientists, ethicists, and other authorities, the book offers authoritative recommendations regarding the use of existing stem cell lines versus new lines in research, the important role of the federal government in this field of research, and other fundamental issues.

In 2000, after receiving bypass surgery, an angioplasty, and entering a cardiac rehabilitation program, van Zyls heart was deteriorating. Turned down by two heart transplant centers, van Zyls only hope was in a new FDA-approved clinical trial for adult stem cell therapies. In this work, van Zyl offers information on the latest adult stem cell treatments for more than a dozen diseases and conditions.

Stem cells offer tremendous promise for advancing health and medicine. Whether being used to replace damaged cells and organs or else by supporting the body's intrinsic repair mechanisms, stem cells hold the potential to treat such debilitating conditions as Parkinson's disease, diabetes, and spinal cord injury. Clinical trials of stem cell treatments are under way in countries around the world, but the evidence base to support the medical use of stem cells remains limited. Despite this paucity of clinical evidence, consumer demand for treatments using stem cells has risen, driven in part by a lack of available treatment options for debilitating diseases as well as direct-to-consumer advertising and public portrayals of stem cell-based treatments. Clinics that offer stem cell therapies for a wide range of diseases and conditions have been established throughout the world, both in newly industrialized countries such as China, India, and Mexico and in developed countries such as the United States and various European nations. Though these therapies are often promoted as being established and effective, they generally have not received stringent regulatory oversight and have not been tested with rigorous trials designed to determine their safety and likely benefits. In the absence of substantiated claims, the potential for harm to patients - as well as to the field of stem cell research in general - may outweigh the potential benefits. To explore these issues, the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research held a workshop in November 2013. "Stem Cell Therapies" summarizes the workshop. Researchers, clinicians, patients, policy makers, and others from North America, Europe, and Asia met to examine the global pattern of treatments and products being offered, the range of patient experiences, and options to maximize the well-being of patients, either by protecting them from treatments that are dangerous or ineffective or by steering them toward treatments that are effective. This report discusses the current environment in which patients are receiving unregulated stem cell offerings, focusing on the treatments being offered and their risks and benefits. The report considers the evidence base for clinical application of stem cell technologies and ways to assure the quality of stem cell offerings.

Laced with hope and promise for sufferers of seemingly incurable illnesses, How Adult Stem Cell Therapies Can Save Your Life: Medicines Best Kept Secret Saved My Life reveals that non-controversial adult stem cell therapies are already available for those with serious diseases and injuries. This book is a practical guide to those seeking adult stem cell treatments with step-by-step instructions on how to use the Internet to locate suitable FDA approved clinical trials for almost all major infirmities Seven years ago, van Zyl suffered cardiac arrest; his heart literally stopped until doctors shocked his chest. Over the next ten months, after receiving bypass surgery, an angioplasty, and entering a cardiac rehabilitation program, van Zyls heart was still deteriorating. Turned down by two heart transplant centers, van Zyls only hope lay in the Food and Drug Administration (FDA), or more specifically, a new FDA-approved clinical trial for adult stem cell therapies. One of 24 patients selected with heart failure, van Zyl entered the aggressive treatment group in 2004, where adult stem cells were harvested from van Zyls own body and injected directly into his failing heart. The results were astonishing. Now 75, van Zyl lives a healthy, vigorous life. How Adult Stem Cell Therapies Can Save Your Life offers a plethora of information on the latest adult stem cell treatments for over a dozen diseases and conditions. While much has been made of the medical viability and ethical concerns of other types of stem cell therapies, van Zyl is living proof that adult stem cell therapies can save lives.

The Healing Cell is an easy to read, carefully researched, and clear-eyed view of medicine many decades in the making that is now paying off with treatments that repair damaged hearts, restore sight, kill cancer, cure diabetes, heal burns, and stop the march of such degenerative diseases as Alzheimer's, multiple sclerosis, and Lou Gehrig's disease. The emotionally and intellectually stimulating stories throughout the book dramatically illustrate that stem cell therapies can change the way we live our lives after being afflicted by a disease or trauma. The book is the result of a unique collaboration between the Vatican's Pontifical Council for Culture and the Stem for Life Foundation. It includes a special address by His Holiness Benedict XVI, urging increased support and awareness for advancements in adult stem cell research.

Perinatal Stem Cells provides researchers and clinicians with a comprehensive description of the current clinical and pre-clinical applications of stem cells derived from perinatal sources, such as amniotic fluid, placenta and placental membranes, the umbilical cord and Wharton's jelly. It's compiled by leading experts in the field, offering readers detailed insights into sources of perinatal stem cells and their potential for disease treatment. Therapeutic applications of perinatal stem cells include the treatment of in utero and pregnancy related diseases, cardiac disease, liver disease, pulmonary disease, inflammatory diseases, for hematopoietic regeneration, and for neural protection after stroke or traumatic brain injury. In addition, the rapid advance in clinical translation and commercialization of perinatal stem cell therapies is highlighted in a section on Clinical and Industry Perspective which provides insight into the new opportunities and challenges involved in this novel and exciting industry. - Explores current clinical and pre-clinical application of stem cells derived from perinatal sources - Offers detailed insight into sources of perinatal stem cells and their potential for disease treatment - Discusses progress in the manufacturing, banking and clinical translation of perinatal stem cells - Edited by a world-renowned team to present a complete story of the development and promise of perinatal stem cells

Julia Szabo was a nationally-recognized pet reporter when her dog Sam collapsed from osteoarthritis. Diligently researching how to restore his quality of life, she discovered Vet-Stem, a service that provides cutting-edge regeneration therapy for pets, using stem cells harvested from animals' own tissue. Just hours after receiving IV and intra-joint injections, Sam began aging backward--which left Julia wondering why this simple, effective treatment was not available for humans. Julia suffered from chronic inflammatory bowel disease, and after witnessing Sam's astonishing recovery, she set out on a curious quest: to be treated like a dog by a doctor as competent as her vet! After a four-year wait, Julia became the first American to be successfully cured of a perirectal fistula with stem cells derived from her own fat. With this amazing true story of how a pack of shelter dogs she rescued from death row came to save her life, Julia hopes to inspire and inform readers about exciting healthcare options available to them and their cherished animal companions.

An engaging introduction to stem cells for young scientists How do you heal when you cut your skin or break a bone? How does your body keep making new blood or brain cells, or even second teeth? How does a plant keep growing larger? The answers lie in stem cells, which are found in every growing plant and animal. Keeping the subject simple enough for young readers, a pioneer of stem cell research explains cells, tissues, normal growth, what can go wrong, and how to fix it.